• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza virus A subtype H1N1 is inhibited by methylated beta-lactoglobulin

tetano

Editor, Senior Moderator
J Dairy Res. 2010 Sep 8:1-8. [Epub ahead of print]
Influenza virus A subtype H1N1 is inhibited by methylated beta-lactoglobulin.

Sitohy M, Scanu M, Besse B, Mollat C, Billaudel S, Haertl? T, Chobert JM.

UR 1268 Biopolym?res Interactions Assemblages, INRA, F-44300 Nantes.
Abstract

Addition of methylated beta-lactoglobulin (Met-BLG) in the medium of MDCK cell lines infected with influenza virus subtype H1N1 reduced hemagglutination activity (HA) in a concentration dependent manner. Antiviral activity of Met-BLG depended on its concentration, viral load, and duration of infection. Using 17 mug/ml of Met-BLG inhibited 50% of HA of H1N1 grown in MDCK cells at 1 MOI after 24 h incubation at 37 degrees C and in 5% CO2. Extension of incubation time enhanced antiviral action since the same concentration of Met-BLG inhibited about 61% of viral activity after 48 h. This viral inhibition was accompanied by a protection of MDCK cells as observed by using neutral red or by direct microscope examination. Reduction of viral RNA replication upon the addition of Met-BLG (50 mug/ml) was observed by real time-PCR showing a reduction of viral log value of about 0.9. When viral stock solution was mixed with 25 mug/ml Met-BLG in absence of cell lines, the morphology and viability of virus particles were significantly affected as observed by electron microscopy, and the number of intact virus particles was reduced by roughly 65%.

PMID: 20822565 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/20822565
 
Back
Top Bottom